Uncategorized - February 23, 2022
A precision medicine approach treats child with neuroblastoma
Swedish researchers and doctors have successfully treated a child with neuroblastoma by using a tailored precision medicine approach. “Combining genetic mapping and biological understanding with a new targeted treatment is precision medicine made real, which can make a difference and cure more children who have cancer,” says co-last author Per Kogner (Karolinska Institutet/Astrid Lindgren Children’s […]
Clinical Trials - February 16, 2022
Elypta launches Multi-Cancer Early Detection screening study
Elypta has announced the launch of a clinical study intended to validate the diagnostic performance of GAGomes – the complete profile of human glycosaminoglycans – as metabolic biomarkers for Multi-Cancer Early Detection (MCED). The study, LEVANTIS-0087A (LEV87A), aims to detect any-type cancer in adults who show no symptoms or have any recent history of cancer. […]
Uncategorized - January 19, 2022
160 million SEK invested in Campus Solna
Akademiska Hus is investing 160 million SEK in reconstructing Fysiologen into modern offices and laboratories. The reconstruction is planned to begin in February 2022 and ready for occupation, in stages, during 2023. A vivid life science district Campus Solna, connecting Stockholm and Solna, has become a vivid new district, consisting of accommodations, commerce, subway, culture […]
Pharma Business - December 20, 2021
Sweden Biomanufacturing Center has been inaugurated
AstraZeneca’s new facility for the production of next generation biologics will create almost 900 new jobs. Sweden Biomanufacturing Center (SBC) is located in Södertälje. “It is no coincidence that we have chosen to launch this production site in Sweden. Sweden is in many ways attractive and we will continue to invest here, given Sweden’s strong […]
In a new job - December 1, 2021
Immunovia’s CEO to step down
Immunovia has announced that the company’s President and Chief Executive Officer, Patrik Dahlen, has informed the Board of Directors of his intention to step down, for personal reasons. The search for a new CEO will start immediately, states the company. Patrik Dahlen will remain with the company for another six months to ensure an orderly […]
Collaboration - November 30, 2021
Immunicum and PCI Biotech extend their collaboration
Immunicum and PCI Biotech Holding have announced an extension of their current research collaboration to explore novel cancer vaccination treatments. The companies jointly research the possibility to overcome current hurdles in cancer immunotherapy by introducing tumor independent immune targets into the tumor microenvironment, in combination with vaccination or adoptive immunotherapies. The so-called Tumor Independent Antigen […]
